Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Associations of Genes for Killer Cell Immunoglobulin-like Receptors and Their Human Leukocyte Antigen-A/B/C Ligands with Abdominal Aortic Aneurysm.

Tytuł:
Associations of Genes for Killer Cell Immunoglobulin-like Receptors and Their Human Leukocyte Antigen-A/B/C Ligands with Abdominal Aortic Aneurysm.
Autorzy:
Dubis J; Research and Development Centre, Regional Specialist Hospital, 51-124 Wroclaw, Poland.
Niepiekło-Miniewska W; Laboratory of Immunogenetics and Tissue Immunology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, Poland.
Jędruchniewicz N; Research and Development Centre, Regional Specialist Hospital, 51-124 Wroclaw, Poland.
Sobczyński M; Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland.
Witkiewicz W; Department of Vascular Surgery, Regional Specialist Hospital in Wroclaw, 51-124 Wrocław, Poland.
Zapotoczny N; Department of Vascular Surgery, Regional Specialist Hospital in Wroclaw, 51-124 Wrocław, Poland.
Kuśnierczyk P; Laboratory of Immunogenetics and Tissue Immunology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, Poland.
Źródło:
Cells [Cells] 2021 Nov 30; Vol. 10 (12). Date of Electronic Publication: 2021 Nov 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI
MeSH Terms:
Genetic Association Studies*
Genetic Predisposition to Disease*
Aortic Aneurysm, Abdominal/*genetics
HLA Antigens/*genetics
Receptors, KIR/*genetics
Adult ; Aged ; Aged, 80 and over ; Body Mass Index ; Case-Control Studies ; Coronary Artery Disease/genetics ; Female ; HLA Antigens/metabolism ; Haplotypes/genetics ; Humans ; Ligands ; Male ; Middle Aged ; Receptors, KIR/metabolism
References:
Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):e83-e90. (PMID: 30811252)
J Vasc Surg. 2007 Mar;45(3):475-80. (PMID: 17321339)
Gene. 2013 Sep 25;527(2):594-600. (PMID: 23831511)
Front Immunol. 2018 Jul 25;9:1716. (PMID: 30090105)
Clin Genet. 2020 Jun;97(6):815-826. (PMID: 31957007)
Annu Rev Genomics Hum Genet. 2013;14:301-23. (PMID: 23875801)
Ann N Y Acad Sci. 2006 Nov;1085:117-32. (PMID: 17182928)
Circ Res. 2005 Apr 1;96(6):675-83. (PMID: 15731463)
Vascul Pharmacol. 2010 Jul-Aug;53(1-2):11-21. (PMID: 20347049)
Sci Immunol. 2016 Sep;1(3):. (PMID: 27868107)
J Immunol. 2020 Sep 1;205(5):1323-1330. (PMID: 32709660)
Immunogenetics. 2007 Feb;59(2):145-58. (PMID: 17200871)
Front Immunol. 2017 Jun 12;8:675. (PMID: 28659916)
Int J Environ Res Public Health. 2018 Dec 10;15(12):. (PMID: 30544688)
Semin Immunol. 2008 Dec;20(6):343-52. (PMID: 18635379)
J Vasc Res. 2020;57(5):276-290. (PMID: 32610319)
Front Immunol. 2021 Mar 12;12:624687. (PMID: 33777006)
J Infect Dis. 2010 Nov 1;202 Suppl 3:S356-60. (PMID: 20887224)
J Immunol. 2021 Feb 15;206(4):849-860. (PMID: 33441440)
Ann N Y Acad Sci. 2006 Nov;1085:392-5. (PMID: 17182961)
Hum Immunol. 2020 Feb - Mar;81(2-3):49-51. (PMID: 31902540)
BMC Med Genet. 2019 Jun 7;20(1):102. (PMID: 31174489)
Hum Immunol. 2015 Apr;76(4):297-300. (PMID: 25700961)
Am J Physiol Heart Circ Physiol. 2015 Sep;309(5):H719-27. (PMID: 26116712)
Int J Mol Sci. 2015 May 18;16(5):11196-212. (PMID: 25993291)
Atherosclerosis. 2013 Feb;226(2):321-7. (PMID: 23137825)
Eur J Vasc Endovasc Surg. 2006 May;31(5):453-63. (PMID: 16414293)
Genes (Basel). 2020 Mar 22;11(3):. (PMID: 32235781)
J Immunol. 2003 Dec 15;171(12):6640-9. (PMID: 14662867)
Ann Vasc Surg. 2016 Oct;36:55-63. (PMID: 27364735)
Immunol Rev. 2015 Sep;267(1):117-36. (PMID: 26284474)
BMC Genomics. 2007 Jul 16;8:237. (PMID: 17634102)
Hum Immunol. 2011 Jul;72(7):558-65. (PMID: 21513754)
Autoimmun Rev. 2018 Feb;17(2):142-154. (PMID: 29180124)
Cardiovasc Res. 2013 Jul 15;99(2):232-41. (PMID: 23459103)
Front Immunol. 2021 Feb 19;12:616853. (PMID: 33679757)
Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1746-55. (PMID: 26044582)
Front Immunol. 2019 Nov 29;10:2755. (PMID: 31849952)
Eur J Vasc Endovasc Surg. 2011 Jan;41 Suppl 1:S1-S58. (PMID: 21215940)
Curr Opin Immunol. 2018 Feb;50:102-111. (PMID: 29413815)
Nat Rev Cardiol. 2011 Feb;8(2):92-102. (PMID: 21079638)
PLoS One. 2019 Jul 16;14(7):e0218990. (PMID: 31310631)
Immunology. 2010 Jan;129(1):8-19. (PMID: 20028428)
Atherosclerosis. 2012 May;222(1):278-83. (PMID: 22425168)
Br J Surg. 2006 Jan;93(1):46-54. (PMID: 16315339)
Genome Biol. 2017 Apr 27;18(1):76. (PMID: 28449694)
Eur J Vasc Endovasc Surg. 2003 Aug;26(2):215-8. (PMID: 12917841)
Blood. 2010 Feb 11;115(6):1166-74. (PMID: 19903900)
Blood Adv. 2020 Oct 13;4(19):4955-4964. (PMID: 33049053)
Contributed Indexing:
Keywords: BMI; CAD; HLA; KIR; abdominal aortic aneurism; aneurysm diameter; genetics; immune cells
Substance Nomenclature:
0 (HLA Antigens)
0 (Ligands)
0 (Receptors, KIR)
Entry Date(s):
Date Created: 20211224 Date Completed: 20220119 Latest Revision: 20220119
Update Code:
20240105
PubMed Central ID:
PMC8699266
DOI:
10.3390/cells10123357
PMID:
34943866
Czasopismo naukowe
Abdominal aortic aneurysm (AAA) is an immune-mediated disease with a genetic component. The multifactorial pathophysiology is not clear and there is still no pharmacotherapy to slow the growth of aneurysms. The signal integration of cell-surface KIRs (killer cell immunoglobulin-like receptors) with HLA (ligands, human leukocyte class I antigen molecules) modulates the activity of natural killer immune cells. The genetic diversity of the KIR/HLA system is associated with the risk of immune disorders. This study was a multivariate analysis of the association between genetic variants of KIRs, HLA ligands, clinical data and AAA formation. Genotyping was performed by single polymerase chain reaction with sequence-specific primers using commercial assays. Patients with HLA-A-Bw4 have a larger aneurysm by an average of 4 mm ( p = 0.008). We observed a relationship between aneurysm diameter and BMI in patients with AAA and co-existing CAD; its shape was determined by the presence of HLA-A-Bw4. There was also a nearly 10% difference in KIR3DL1 allele frequency between the study and control groups. High expression of the cell surface receptor KIR3DL1 may protect, to some extent, against AAA. The presence of HLA-A-Bw4 may affect the rate of aneurysm growth and represents a potential regional pathogenetic risk of autoimmune injury to the aneurysmal aorta.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies